(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
10 day averaged volume of Ascendis Pharma is 294320
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Tue Oct 2024 | 126.77 | 129.56 | 129.69 | 124.02 | 1.078 times |
| 28 Mon Oct 2024 | 129.44 | 131.25 | 133.97 | 129.14 | 0.846 times |
| 25 Fri Oct 2024 | 130.32 | 129.93 | 131.42 | 129.17 | 0.6 times |
| 24 Thu Oct 2024 | 129.81 | 128.00 | 130.79 | 128.00 | 0.699 times |
| 23 Wed Oct 2024 | 127.69 | 128.73 | 130.05 | 126.44 | 0.972 times |
| 22 Tue Oct 2024 | 129.07 | 127.36 | 129.95 | 126.02 | 0.511 times |
| 21 Mon Oct 2024 | 128.66 | 130.44 | 130.66 | 125.59 | 0.922 times |
| 18 Fri Oct 2024 | 129.90 | 127.70 | 131.89 | 126.59 | 1.296 times |
| 17 Thu Oct 2024 | 126.66 | 129.52 | 130.00 | 126.00 | 1.579 times |
| 16 Wed Oct 2024 | 130.31 | 127.49 | 132.63 | 127.47 | 1.614 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 126.1 as stoploss in an intra day buy trade for a target of 131.7. However, stock will show a bearish move below 126.1.
Share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Target | 111.09 |
| Downside Target | 120.18 |
| Downside Target | 124.02 |
| Upside Target | 130.57 |
| Upside Target | 139.56 |
| Upside Target | 140.09 |
| Upside Target | 142.21 |
| Upside Target | 143.53 |
| Upside Target | 144.62 |
| Upside Target | 149.31 |
| Upside Target | 149.67 |
| Upside Target | 155.53 |
Intraday share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Intraday Target | 122.54 |
| Downside Intraday Target | 118.3 |
| Upside Intraday Target | 132.49 |
| Upside Intraday Target | 138.2 |
| Upside Intraday Target | 128.25 |
Weekly technical analysis of Ascendis Pharma (ASND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Tue Oct 2024 | 126.77 | 131.25 | 133.97 | 124.02 | 0.519 times |
| 25 Fri Oct 2024 | 130.32 | 130.44 | 131.42 | 125.59 | 0.493 times |
| 18 Fri Oct 2024 | 129.90 | 128.63 | 132.63 | 125.40 | 0.792 times |
| 11 Fri Oct 2024 | 128.87 | 141.07 | 143.53 | 127.11 | 1.249 times |
| 04 Fri Oct 2024 | 142.67 | 143.69 | 149.67 | 139.56 | 0.916 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Tue Oct 2024 | 126.77 | 149.31 | 149.31 | 124.02 | 0.375 times |
| 30 Mon Sep 2024 | 149.31 | 136.41 | 155.53 | 111.09 | 2.447 times |
| 30 Fri Aug 2024 | 138.45 | 133.56 | 144.62 | 120.18 | 1.539 times |
| 31 Wed Jul 2024 | 133.50 | 135.68 | 142.21 | 130.57 | 1.008 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term and the sell signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.74 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term and the sell signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.74 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.